Pharmacokinetics and Drug‐Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping

The World Health Organization guidelines recommend that individuals living with HIV receive ≥ 6 months of isoniazid preventive therapy, including pregnant women. Yet, plasma isoniazid exposure during pregnancy, in the antiretroviral therapy era, has not been well‐described. We investigated pregnancy...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Clin Pharmacol Ther
मुख्य लेखकों: Gausi, Kamunkhwala, Wiesner, Lubbe, Norman, Jennifer, Wallis, Carole L., Onyango‐Makumbi, Carolyne, Chipato, Tsungai, Haas, David W., Browning, Renee, Chakhtoura, Nahida, Montepiedra, Grace, Aaron, Lisa, McCarthy, Katie, Bradford, Sarah, Vhembo, Tichaona, Stranix‐Chibanda, Lynda, Masheto, Gaerolwe R., Violari, Avy, Mmbaga, Blandina T., Aurpibul, Linda, Bhosale, Ramesh, Nevrekhar, Neetal, Rouzier, Vanessa, Kabugho, Enid, Mutambanengwe, Mercy, Chanaiwa, Vongai, Nyati, Mandisa, Mhembere, Tsungai, Tongprasert, Fuanglada, Hesseling, Anneke, Shin, Katherine, Zimmer, Bonnie, Costello, Diane, Jean‐Philippe, Patrick, Sterling, Timothy R., Theron, Gerhard, Weinberg, Adriana, Gupta, Amita, Denti, Paolo
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: John Wiley and Sons Inc. 2020
विषय:
Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC8048881/
https://ncbi.nlm.nih.gov/pubmed/32909316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.2044
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन